Clin Pharmacol Adv Appl 8:177189 Atashrazm F, Hammond D, Perera G, Dobson-Stone C, Mueller N, Pickford R, Kim WS, Kwok JB, Lewis SJG, Halliday GM, Dzamko N (2018) Reduced glucocerebrosidase activity in monocytes from patients with Parkinsons disease
,
WritingReview and Editing: SM, HS, BG, and LM
Cardiovascular risk Research trials (such as EXAMINE, SAVOR-TIMI-53, TECOS, and CARMELINA) have shown that certain DPP-4 inhibitors do not adversely impact the heart and are cardiovascularly safe [7], [14]
Unlike fillers, which add instant volume, these treatments work slowly to improve the skins structure over time
Effect of Liraglutide 3.0 Mg in Individuals With Obesity and Moderate or Severe Obstructive Sleep Apnea: The Scale Sleep Apnea Randomized Clinical Trial